Published work in other systems has shown that the α-2,6 sialylation mediated by ST6GAL1 is associated with a less differentiated phenotype in mouse mammary tumors12 and enhanced PI3K/AKT signaling in human cancer cells45, 46. The gene discussed is ST6GAL1; the disease is cancer.